Helicobacter Pylori Antigen Test segmentation by application reveals three primary use cases: clinical diagnosis, population screening, and research. Clinical diagnosis accounts for the largest share, driven by the need for rapid, non‑invasive confirmation of active infection in symptomatic patients; this segment contributes approximately 65 % of total revenue, reflecting its dominance in hospital and outpatient settings. Screening applications target asymptomatic or high‑risk groups, such as school‑aged children or elderly populations, and represent roughly 25 % of market value, supported by public‑health initiatives and insurance reimbursement policies. The research niche, encompassing drug‑development trials, epidemiological studies, and assay validation, occupies the remaining 10 % of the market, where specialized kits are procured in lower volumes but at higher unit prices. Collectively, these application categories shape the overall market size and guide resource allocation across manufacturers and distributors. The distribution is visualized in the accompanying pie‑chart, aligning with the Helicobacter Pylori Antigen Test segmentation framework.